GR3005542T3 - - Google Patents

Info

Publication number
GR3005542T3
GR3005542T3 GR920401871T GR920401871T GR3005542T3 GR 3005542 T3 GR3005542 T3 GR 3005542T3 GR 920401871 T GR920401871 T GR 920401871T GR 920401871 T GR920401871 T GR 920401871T GR 3005542 T3 GR3005542 T3 GR 3005542T3
Authority
GR
Greece
Application number
GR920401871T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005542T3 publication Critical patent/GR3005542T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920401871T 1987-10-07 1992-08-27 GR3005542T3 (US20050192411A1-20050901-C00001.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10593987A 1987-10-07 1987-10-07
US21130888A 1988-06-24 1988-06-24

Publications (1)

Publication Number Publication Date
GR3005542T3 true GR3005542T3 (US20050192411A1-20050901-C00001.png) 1993-06-07

Family

ID=26803117

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401871T GR3005542T3 (US20050192411A1-20050901-C00001.png) 1987-10-07 1992-08-27

Country Status (18)

Country Link
EP (1) EP0311067B1 (US20050192411A1-20050901-C00001.png)
JP (1) JP2722219B2 (US20050192411A1-20050901-C00001.png)
KR (1) KR960007748B1 (US20050192411A1-20050901-C00001.png)
CN (1) CN1053570C (US20050192411A1-20050901-C00001.png)
AU (1) AU608069B2 (US20050192411A1-20050901-C00001.png)
CA (1) CA1314485C (US20050192411A1-20050901-C00001.png)
DE (1) DE3874072T2 (US20050192411A1-20050901-C00001.png)
DK (1) DK168270B1 (US20050192411A1-20050901-C00001.png)
ES (1) ES2046270T3 (US20050192411A1-20050901-C00001.png)
FI (1) FI89241C (US20050192411A1-20050901-C00001.png)
GR (1) GR3005542T3 (US20050192411A1-20050901-C00001.png)
HU (1) HU200916B (US20050192411A1-20050901-C00001.png)
IE (1) IE61130B1 (US20050192411A1-20050901-C00001.png)
IL (1) IL87943A (US20050192411A1-20050901-C00001.png)
NO (1) NO176746C (US20050192411A1-20050901-C00001.png)
NZ (1) NZ226482A (US20050192411A1-20050901-C00001.png)
PH (1) PH26155A (US20050192411A1-20050901-C00001.png)
PT (1) PT88682B (US20050192411A1-20050901-C00001.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
SK279684B6 (sk) * 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
EP0812195B1 (en) 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
TR199701092T1 (xx) * 1995-04-03 1998-01-21 Chugai Seiyaku Kabushiki Kaisha Et Al Sukralfat içeren farmakotik kompozisyonlar.
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6232351B1 (en) * 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US20020094345A1 (en) 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
CA2679070C (en) * 2007-03-12 2016-04-26 Nektar Therapeutics Oligomer-antihistamine conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3878217A (en) 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US4285957A (en) 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
JPS5788117A (en) * 1980-11-21 1982-06-01 Smithkline Corp Gelatin capsule containing triamterene
JPS5877810A (ja) * 1981-11-01 1983-05-11 Taiho Yakuhin Kogyo Kk ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
ZA838033B (en) * 1982-11-01 1984-06-27 Merrell Dow Pharma Sustained release solid dosage forms having non-uniform distribution of active ingredient
GB2142824B (en) * 1983-07-07 1987-02-11 American Home Prod Pharmaceutical composition containing a liquid lubricant

Also Published As

Publication number Publication date
JPH01128925A (ja) 1989-05-22
FI884545A (fi) 1989-04-08
NO884443L (no) 1989-04-10
JP2722219B2 (ja) 1998-03-04
DK168270B1 (da) 1994-03-07
DE3874072T2 (de) 1993-04-08
FI89241C (fi) 1993-09-10
DE3874072D1 (de) 1992-10-01
CA1314485C (en) 1993-03-16
IE61130B1 (en) 1994-10-05
DK559088A (da) 1989-04-08
NO176746C (no) 1995-05-24
HUT48816A (en) 1989-07-28
KR960007748B1 (ko) 1996-06-12
NZ226482A (en) 1990-09-26
CN1032738A (zh) 1989-05-10
NO176746B (no) 1995-02-13
PT88682B (pt) 1992-12-31
PT88682A (pt) 1988-11-01
CN1053570C (zh) 2000-06-21
EP0311067B1 (en) 1992-08-26
IL87943A (en) 1992-02-16
HU200916B (en) 1990-09-28
ES2046270T3 (es) 1994-02-01
IE883033L (en) 1989-04-07
KR890006236A (ko) 1989-06-12
EP0311067A1 (en) 1989-04-12
IL87943A0 (en) 1989-03-31
FI89241B (fi) 1993-05-31
AU2345988A (en) 1989-04-20
AU608069B2 (en) 1991-03-21
FI884545A0 (fi) 1988-10-03
PH26155A (en) 1992-03-18
DK559088D0 (da) 1988-10-06
NO884443D0 (no) 1988-10-06

Similar Documents

Publication Publication Date Title
FR2617791B1 (US20050192411A1-20050901-C00001.png)
IN166898B (US20050192411A1-20050901-C00001.png)
IN168936B (US20050192411A1-20050901-C00001.png)
GR3004755T3 (US20050192411A1-20050901-C00001.png)
GR3006879T3 (US20050192411A1-20050901-C00001.png)
GR3007431T3 (US20050192411A1-20050901-C00001.png)
GR3007657T3 (US20050192411A1-20050901-C00001.png)
DE3866159D1 (US20050192411A1-20050901-C00001.png)
IN168912B (US20050192411A1-20050901-C00001.png)
GR3007660T3 (US20050192411A1-20050901-C00001.png)
FR2616965B1 (US20050192411A1-20050901-C00001.png)
DE3875765D1 (US20050192411A1-20050901-C00001.png)
GR3005542T3 (US20050192411A1-20050901-C00001.png)
DE3784067D1 (US20050192411A1-20050901-C00001.png)
FR2622959B1 (US20050192411A1-20050901-C00001.png)
GR3005524T3 (US20050192411A1-20050901-C00001.png)
DE3890751T (US20050192411A1-20050901-C00001.png)
IN168517B (US20050192411A1-20050901-C00001.png)
FI890413A0 (US20050192411A1-20050901-C00001.png)
IN168008B (US20050192411A1-20050901-C00001.png)
IN169731B (US20050192411A1-20050901-C00001.png)
IN166960B (US20050192411A1-20050901-C00001.png)
GR3007126T3 (US20050192411A1-20050901-C00001.png)
IN166902B (US20050192411A1-20050901-C00001.png)
GR3007207T3 (US20050192411A1-20050901-C00001.png)